[The use of dalargin for treating duodenal peptic ulcer recurrences on an outpatient basis].
Buglak
N P
NP
Grigorenko
E I
EI
Dudar'
L V
LV
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000553:Ambulatory Care; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy*; D016308:Enkephalin, Leucine-2-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007478:Iontophoresis; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction
D000336:Aerosols; D000897:Anti-Ulcer Agents; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Primenenie dalargina dlia lecheniia retsidivov iazvennoĭ bolezni dvenadtsatiperstnoĭ kishki v ambulatornykh usloviiakh.